Illumina Inc (ILMN)

ILMN (NASDAQ:Drugs)
$185.83
neg -0.43
-0.23%
Today's Range: 185.54 - 191.20 | ILMN Avg Daily Volume: 1,226,900
Last Update: 11/21/14 - 4:00 PM EST
Volume: 796,127
YTD Performance: 71.83%
Open: $190.52
Previous Close: $186.26
52 Week Range: $92.45 - $197.37
Oustanding Shares: 142,000,000
Market Cap: 26,984,260,000
6-Month Chart
TheStreet Ratings Grade for ILMN
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 12 11 10 10
Moderate Buy 0 0 0 0
Hold 5 7 8 8
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.59 1.78 1.89 1.89
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 98.97
Price Earnings Comparisons:
ILMN Sector Avg. S&P 500
98.97 99.10 25.77
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
11.46% 103.87% 552.13%
GROWTH 12 Mo 3 Yr CAGR
Revenue 23.70 0.57 0.16
Net Income -17.20 0.00 0.00
EPS -20.90 -0.01 0.00
Earnings for ILMN:
EBITDA 0.26B
Revenue 1.42B
Average Earnings Estimates
Qtr (12/14) Qtr (03/15) FY (12/14) FY (12/15)
Average Estimate $0.77 $0.72 $2.64 $3.15
Number of Analysts 13 8 14 14
High Estimate $0.79 $0.76 $2.66 $3.28
Low Estimate $0.76 $0.67 $2.63 $2.97
Prior Year $0.45 $0.53 $1.80 $2.64
Growth Rate (Year over Year) 71.97% 36.56% 46.83% 19.08%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
It's the only way to deal with this market.
Trends have a great tendency to persist.
And no one thinks it's going to be easy to navigate.
Bullish
Oct 21, 2014 | 7:13 AM EDT
Shares of ILMN now seen reaching $245, according to JMP Securities. Estimates also increased, as the company is seeing higher demand ac...
Bullish
Oct 16, 2014 | 8:09 AM EDT
ILMN was upgraded from Neutral to Overweight, Piper Jaffray said. $192 price target. Channel checks suggest accelerating demand for HiS...
Here are three stocks to avoid at current levels.
Bullish
Aug 20, 2014 | 7:28 AM EDT
ILMN was upgraded from Neutral to Outperform, Wedbush said. $200 price target. Estimates also increased, following the recent Labcorp w...
Bullish
Apr 23, 2014 | 8:11 AM EDT
ILMN was upgraded from Hold to Buy, Maxim Group said. $205 price target. Clinical customers are accelerating adoption and the company i...

That Was the Week That Was Real Money Pro($)

Let's review.
I'd wait until the stock cools off to buy shares.

Columnist Conversations

Well this is confusing...our models were calling for a run to 2072 before a bearish reversal would be possible...
Revenue Trend Apple is one of the most remarkable companies in the world, not just because it has the largest...
HOG has topped out. The stock's twelve day winning streak is ending today with and ugly reversal. HOG o...
Seems like there was a bid underneath at the crucial 2:45 p.m. hour.. day saver? still not sure..

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.